Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T06:52:35.095Z Has data issue: false hasContentIssue false

Ex utero intrapartum treatment to extracorporeal membrane oxygenation: lifesaving management of a giant cervical teratoma

Published online by Cambridge University Press:  01 July 2020

N H Reeve*
Affiliation:
Department of Otolaryngology – Head and Neck Surgery, University of Nevada, Las Vegas School of Medicine, USA
J B Kahane
Affiliation:
Department of Otolaryngology – Head and Neck Surgery, University of Nevada, Las Vegas School of Medicine, USA
A G Spinner
Affiliation:
Department of Otolaryngology – Head and Neck Surgery, University of Nevada, Las Vegas School of Medicine, USA
T J O-Lee
Affiliation:
Department of Otolaryngology – Head and Neck Surgery, Loma Linda University School of Medicine, California, USA
*
Author for correspondence: Dr Nathaniel Reeve, Department of Otolaryngology – Head and Neck Surgery, University of Nevada, Las Vegas School of Medicine, 1701 W Charleston Blvd, Suite 490, Las Vegas, NV 89102, USA E-mail: nathaniel.reeve@unlv.edu
Rights & Permissions [Opens in a new window]

Abstract

Background

Ex utero intrapartum treatment (‘EXIT’ procedure) is a well described method for maintaining maternal–fetal circulation in the setting of airway obstruction from compressive neck masses. When ex utero intrapartum treatment to airway is not feasible, ex utero intrapartum treatment to extracorporeal membrane oxygenation (‘ECMO’) has been described in fetal cardiopulmonary abnormalities.

Objective

This paper presents the case of a massively compressive midline neck teratoma managed with ex utero intrapartum treatment to extracorporeal membrane oxygenation, allowing for neonatal survival, with controlled airway management and subsequent resection.

Case report

A 34-year-old-female presented with a fetal magnetic resonance imaging scan demonstrating a 15 cm compressive midline neck teratoma. Concern for failure of ex utero intrapartum treatment to airway was high. The addition of the ex utero intrapartum treatment to extracorporeal membrane oxygenation procedure provided time for the planned subsequent resection of the mass and tracheostomy.

Conclusion

Ex utero intrapartum treatment procedures allow for securement of the difficult neonatal airway, while maintaining a supply of oxygenated blood to the newborn. Ex utero intrapartum treatment circulation lasts on average less than 30 minutes. The arrival of extracorporeal membrane oxygenation has enabled the survival of neonates with disease processes previously incompatible with life.

Information

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited, 2020
Figure 0

Fig. 1. A T2-weighted fetal magnetic resonance imaging scan conducted at 34 weeks and 5 days gestational age demonstrates polyhydramnios and a large midline complex mass, measuring 14 × 13 × 10 cm, consistent with giant cervicofacial teratoma.

Figure 1

Fig. 2. (a) View of the median sternotomy and extracorporeal membrane oxygenation cannulae. The venous cannula is in the right atrium and the arterial cannula is in the aorta. Also pictured is an iatrogenic laceration to the inferior portion of the cervicofacial mass that occurred as a result of delivery. Cephalad is oriented towards the top right. (b) Infant on extracorporeal membrane oxygenation after transfer to the adjoining operating theatre. Cephalad is oriented towards the bottom.

Figure 2

Fig. 3. (a) Laryngoscopy performed during ex utero intrapartum treatment with no visualisation of the glottis; the uvula (asterisk) and epiglottis (arrow) are highlighted. (b) Laryngoscopy after extracorporeal membrane oxygenation displaying the glottis; the right arytenoid (asterisk) and epiglottis (arrow) are highlighted.

Figure 3

Fig. 4. (a) Contrasted sagittal computed tomography scan on day of life 1, showing a complex midline cervicofacial mass measuring 15 × 14 × 11.3 cm. (b) Cervicofacial mass following resection, measuring 16.2 × 10.5 × 9.1 cm, with a weight of 585 g. Pathology revealed a grade 3 immature teratoma.